On October 10, 2025, Quoin Pharmaceuticals, Ltd. reported entering into a private placement agreement for approximately $16.6 million, aiming to finance corporate activities and R&D efforts, with a closing date on October 14, 2025. The deal includes the issuance of ordinary shares, pre-funded warrants, and several series of ordinary warrants, potentially raising an aggregate of approximately $104.6 million in gross proceeds.